MicroLIQUID

MicroLIQUID

Helps life science, IVD and cell therapy clients transform microfluidic assays into user-friendly, cost-effective, and clinically validated commercial products.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR201520172018201920202021
Revenues<1m<1m<1m1.4m2.0m2.7m
% growth--(22 %)163 %37 %36 %
EBITDA<1m<1m(<1m)1.5m<1m(<1m)
% EBITDA margin3 %6 %(20 %)101 %45 %(12 %)
Profit<1m<1m(<1m)<1m<1m(<1m)
% profit margin3 %5 %(41 %)10 %33 %(19 %)

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound

€12.5k

Grant

€12.5k

Grant

N/A

Support Program
*

N/A

Acquisition
Total Funding€25.0k

Recent News about MicroLIQUID

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.